Related Experiment Video
Updated: Jun 5, 2026
14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Calcium signalling and Alzheimer's disease
1The Babraham Institute, Babraham, Cambridge, CB22 3AT, UK. michael.berridge@bbsrc.ac.uk
Neurochemical Research
|December 25, 2010
Summary
Alzheimer's disease (AD) involves amyloid-dependent disruption of calcium (Ca2+) signalling, impairing learning and memory. This remodelling causes persistent Ca2+ elevation, erasing new memories via long-term depression (LTD) and leading to neurodegeneration.
Area of Science:
- Neuroscience
- Cellular Biology
- Pathology
Background:
- Calcium (Ca2+) ions are crucial regulators of neuronal function, including learning and memory.
- Alzheimer's disease (AD) is characterized by amyloid pathology and cognitive decline.
- Dysregulation of neuronal Ca2+ signalling is implicated in AD pathogenesis.
Purpose of the Study:
- To elucidate how amyloid-dependent Ca2+ signalling remodelling disrupts learning and memory mechanisms in AD.
- To explore the proposed calcium hypothesis of AD.
Main Methods:
- The study proposes a theoretical framework based on existing research.
- It integrates findings on amyloid pathways, Ca2+ signalling, and synaptic plasticity mechanisms like Long-Term Potentiation (LTP) and Long-Term Depression (LTD).
Main Results:
- Amyloid pathway activation remodels neuronal Ca2+ signalling by enhancing Ca2+ influx or release.
- This leads to persistently elevated Ca2+ levels, which promote LTD and erase newly acquired memories.
- While Long-Term Potentiation (LTP) can still form memories, they are rapidly cleared by persistent LTD.
Conclusions:
- The calcium hypothesis of AD posits that disrupted Ca2+ signalling underlies cognitive deficits.
- Persistent Ca2+ elevation and enhanced LTD are key mechanisms for memory erasure in AD.
- Further Ca2+ dysregulation contributes to the neurodegeneration observed in advanced dementia stages.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...